Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?



Rating:

Share or cite this content

Citations should be made in the following way:
H. De Koning (Rotterdam, Netherlands). Update on NELSON including its cost-effectiveness analysis. International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?

Member's Comments

No comment yet.

Related content which might interest you: Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002 Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data Source: ERJ Open Res, 3 (2) 00085-2016; 10.1183/23120541.00085-2016 Year: 2017 Primary asthma prevention amongst children — A cost-effectiveness analysis in a decision-analytic framework Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Cancer And Physical ACtivITY (CAPACITY) trial- A randomised control trial of exercise and self-management in lung cancer: preliminary feasibility results Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study Source: Eur Respir J 2010; 35: 532-539 Year: 2010 Cost-effectiveness analysis of a Home-based disease management intervention for patients with severe COPD alongside the COMET study. Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 Modeling the cost-effectiveness of stratified medicine in COPD Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Cost-effectiveness analysis of asthma treatment strategies Source: Annual Congress 2008 - Rationale of self-education in asthma therapy Year: 2008 Asthma cost-effectiveness analyses: Are we using the recommended outcomes in estimating value? Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease Year: 2017 Evaluation of the effects of the COPDnet comprehensive care model; an interim analysis Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Clinical effectiveness of triple therapy in the management of COPD: A systematic review Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Cost-utility analysis of a Home-based disease management intervention for patients with severe COPD in the COMET study. Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Effectiveness of a spirometric quality assurance program in a large-scale global COPD trial (UPLIFT) Source: Eur Respir J 2004; 24: Suppl. 48, 32s Year: 2004 The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial Source: Annual Congress 2013 –Viral infections: what is new? Year: 2013 Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 A bayesian cost-effectiveness analysis of a telemedicine-based strategy for the management of sleep apnea: A multicenter randomized controlled trial Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Year: 2015